美股市场个股详情

RVMD Revolution Medicines

添加自选
  • 45.140
  • -1.290-2.78%
交易中 12/12 14:21 (美东)
82.10亿总市值-12.33市盈率TTM

关于Revolution Medicines公司

Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司,致力于开发新颖的靶向疗法,以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标,尤其侧重于RAS和mTOR信号通路。 该公司的产品包括RMC-4630,SHP2抑制剂,RAS(ON) 产品组合以及SOS1和4EBP1 / mTORC1程序。

公司介绍

公司代码RVMD
公司名称Revolution Medicines
上市日期2020/02/13
发行价格17.00
成立日期2004
CEODr. Mark A. Goldsmith, M.D., PhD
所属市场纳斯达克
员工数量378
年结日12-31
公司地址700 Saginaw Drive
城市Redwood City
省份加利福尼亚州
国家美国
邮编94063
电话1-650-481-6801

董事高管

  • 姓名
  • 职务
  • 年薪
  • Dr. Mark A. Goldsmith, M.D., PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 1041.12万
  • Jack Anders
  • Chief Financial Officer and Principal Accounting Officer
  • 304.75万
  • Dr. Wei Lin
  • Chief Medical Officer
  • --
  • Margaret A. Horn, J.D.
  • Chief Operating Officer
  • 439.34万
  • Dr. Mary Pinder-Schenck, M.D.
  • Senior Vice President, Head of Medical Affairs
  • --
  • Ryan Asay
  • Senior Vice President, Corporate Affairs
  • --
  • Dr. Mason Shih, M.D.
  • Senior Vice President, Head of Drug Safety
  • --
  • Dr. Jing Yi, PhD
  • Senior Vice President, Head of Program Leadership.
  • --
  • Xiaolin Wang
  • Executive Vice President, Development
  • 323.09万
  • Jeff Cislini
  • Senior Vice President, General Counsel and Secretary
  • --
  • Dr. Stephen M. Kelsey, F.R.C.P.,M.D.
  • President, Research and Development
  • 439.45万
  • Elizabeth McKee Anderson, M.B.A.
  • Independent Director
  • 48.38万
  • Dr. Flavia Borellini, PhD
  • Independent Director
  • 48.91万
  • Alexis A. Borisy, A.M.
  • Lead Independent Director
  • 51.06万
  • Frank K. Clyburn, Jr
  • Independent Director
  • --
  • Dr. Sushil Patel, PhD
  • Independent Director
  • 47.52万
  • Dr. Lorence H. Kim, M.D.
  • Independent Director
  • 49.00万
  • Dr. Thilo Schroeder, PhD
  • Independent Director
  • --
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 72.00万
  • Dr. Barbara L. Weber, M.D.
  • Independent Director
  • 48.02万
热议
美股
综合热度
股票代码
最新价
涨跌幅

暂无数据